1 дек. 2019 г. · The analysis showed lower risks of major adverse cardiovascular or cerebrovascular events, recurrent stroke, and bleeding events for clopidogrel monotherapy ...

28 сент. 2018 г. · Our results suggest that aspirin at a much lower cost than clopidogrel was as effective as clopidogrel in preventing recurrent stroke.

17 дек. 2021 г. · Results revealed that clopidogrel plus aspirin was more effective than aspirin alone in reducing the risk for recurrent stroke (ischemic or hemorrhagic), with ...

Conclusions: Patients with CAD use clopidogrel could further reduce the risk of MACCE, MI, stroke, and BARC major bleeding, compared with the use of aspirin.

27 мар. 2020 г. · Clopidogrel monotherapy was neither inferior nor superior to aspirin monotherapy for the secondary prevention of recurrent cerebrovascular attack following ...

27 апр. 2021 г. · Although DAPT proved superior to aspirin monotherapy in preventing recurrent ischemic strokes, the risk of major and minor hemorrhage was ...

Among patients with an ischaemic stroke while taking aspirin, clopidogrel initiation was associated with fewer recurrent vascular events than aspirin ...

Aspirin monotherapy compared with clopidogrel monotherapy was associated with similar cardiovascular and bleeding outcomes beyond 1 month and up to 1 year after ...

Compared with aspirin, clopidogrel was associated with reductions in MACE and stroke (ischemic and hemorrhagic) following DAPT completion after PCI.